{"id":"https://openalex.org/W2809309196","doi":"https://doi.org/10.1093/annonc/mdy151.233","title":"Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)","display_name":"Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC)","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2809309196","doi":"https://doi.org/10.1093/annonc/mdy151.233","mag":"2809309196"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdy151.233","doi":"https://doi.org/10.1093/annonc/mdy151.233","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy151.233","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1093/annonc/mdy151.233","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019473289","display_name":"Zev A. Wainberg","orcid":"https://orcid.org/0000-0002-7142-1246","observed_orcids":["https://orcid.org/0000-0002-7142-1246"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Z. Wainberg","raw_affiliation_strings":["Ronald Reagan UCLA Medical Center, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ronald Reagan UCLA Medical Center, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I2801272649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005968330","display_name":"John H. Strickler","orcid":"https://orcid.org/0000-0001-7579-1175","observed_orcids":["https://orcid.org/0000-0001-7579-1175"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Strickler","raw_affiliation_strings":["Duke University Medical Center, Durham, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069690249","display_name":"Michael S. Gordon","orcid":"https://orcid.org/0000-0002-7679-9504","observed_orcids":["https://orcid.org/0000-0002-7679-9504"]},"institutions":[{"id":"https://openalex.org/I4210130412","display_name":"HonorHealth","ror":"https://ror.org/03szbwj17","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130412"]},{"id":"https://openalex.org/I4210146652","display_name":"Pinnacle Oncology Hematology","ror":"https://ror.org/043rqx383","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Gordon","raw_affiliation_strings":["Pinnacle Oncology Hematology/HonorHealth Research Institute, Scottsdale, Arizona, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pinnacle Oncology Hematology/HonorHealth Research Institute, Scottsdale, Arizona, USA","institution_ids":["https://openalex.org/I4210130412","https://openalex.org/I4210146652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015591858","display_name":"Minal A. Barve","orcid":"https://orcid.org/0009-0007-4259-7457","observed_orcids":["https://orcid.org/0009-0007-4259-7457"]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Barve","raw_affiliation_strings":["Mary Crowley Medical Research Centers, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Medical Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100403088","display_name":"Lin Wang","orcid":"https://orcid.org/0000-0001-5734-8612","observed_orcids":["https://orcid.org/0000-0001-5734-8612"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Wang","raw_affiliation_strings":["Oncology Early Development, AbbVie Inc., Redwood City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Early Development, AbbVie Inc., Redwood City, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023949142","display_name":"H. Yue","orcid":"https://orcid.org/0000-0002-6315-3368","observed_orcids":["https://orcid.org/0000-0002-6315-3368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Yue","raw_affiliation_strings":["Oncology Early Development, AbbVie Inc., Redwood City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Early Development, AbbVie Inc., Redwood City, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042853916","display_name":"Mona Motwani","orcid":"https://orcid.org/0000-0003-0912-5478","observed_orcids":["https://orcid.org/0000-0003-0912-5478"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Motwani","raw_affiliation_strings":["Oncology Early Development, AbbVie Inc., North Chicago, Illinois, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Early Development, AbbVie Inc., North Chicago, Illinois, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039202929","display_name":"Sreeneeranj Kasichayanula","orcid":"https://orcid.org/0000-0002-2671-8550","observed_orcids":["https://orcid.org/0000-0002-2671-8550"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Kasichayanula","raw_affiliation_strings":["Clinical Pharmacology and Pharmacometrics, AbbVie Inc., Redwood City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology and Pharmacometrics, AbbVie Inc., Redwood City, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032812187","display_name":"Louie Naumovski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Naumovski","raw_affiliation_strings":["Oncology Early Development, AbbVie Inc., Redwood City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Early Development, AbbVie Inc., Redwood City, California, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003060935","display_name":"Erika Paige Hamilton","orcid":"https://orcid.org/0000-0002-1911-0336","observed_orcids":["https://orcid.org/0000-0002-1911-0336"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Hamilton","raw_affiliation_strings":["Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":{"value":5080,"currency":"USD","value_usd":5080},"fwci":0.189,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.5513532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"29","issue":null,"first_page":"v66","last_page":"v66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":0.8529999852180481},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8429999947547913},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.6840000152587891},{"id":"https://openalex.org/keywords/delta-like-ligand-4","display_name":"DLL4","score":0.9599999785423279},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.6549999713897705},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6209999918937683},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.781000018119812},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.699999988079071},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.31200000643730164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9455868005752563},{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.9424116611480713},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.722453773021698},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7045374512672424},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5773277878761292},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5241489410400391},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4516318738460541},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.4209803342819214},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2903151214122772},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.26756584644317627},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.19553285837173462}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdy151.233","doi":"https://doi.org/10.1093/annonc/mdy151.233","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy151.233","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdy151.233","doi":"https://doi.org/10.1093/annonc/mdy151.233","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy151.233","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2808731262","https://openalex.org/W2913580651","https://openalex.org/W2890578954","https://openalex.org/W2667592056","https://openalex.org/W2589412553","https://openalex.org/W4289711815","https://openalex.org/W2274750238","https://openalex.org/W2908987311","https://openalex.org/W3103562921","https://openalex.org/W4407058601"],"abstract_inverted_index":{"Introduction:":[0],"ABT-165":[1,44],"is":[2],"a":[3,34,55],"first-in-class":[4],"dual-variable":[5],"domain":[6],"immunoglobulin":[7],"with":[8,49,54,58],"specificity":[9],"for":[10],"both":[11],"vascular":[12],"endothelial":[13],"growth":[14],"factor":[15],"and":[16],"delta-like":[17],"ligand":[18],"4":[19],"(DLL4)":[20],"that":[21],"has":[22],"demonstrated":[23],"encouraging":[24],"preliminary":[25],"clinical":[26],"antitumor":[27],"activity":[28],"as":[29],"monotherapy.":[30],"As":[31],"part":[32],"of":[33,43],"phase":[35],"1":[36],"trial,":[37],"we":[38],"evaluated":[39],"an":[40],"expansion":[41],"cohort":[42],"plus":[45],"FOLFIRI":[46],"in":[47],"patients":[48],"2L":[50],"CRC":[51],"previously":[52],"treated":[53],"fluoropyrimidine/oxaliplatin":[56],"regimen":[57],"or":[59],"without":[60],"bevacizumab.":[61]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2018-06-29T00:00:00"}